BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Virginia Tech//VTCalendar//EN
BEGIN:VEVENT
DTSTAMP:20251103T211000Z
UID:AAAOxXAAVAADjNcAAU@thor.lawrence.edu
CATEGORIES:Speakers
DTSTART:20251103T211000Z
DTEND:20251103T222000Z
SUMMARY:Recent Advances in Biology Lecture Series: Holly 
 Schroeder, PhD.
ORGANIZER;CN="Biology Department":
 about:blank
DESCRIPTION:
 Speaker: \n
 Holly Schroeder, PhD\n
 Scientist at Asklepios Biopharmaceutical\n
 \n
 Title:\n
 AAV Gene Therapy and Development from discovery 
 to IND-enabling studies\n
 \n
 Abstract:\n
 Adeno-associated virus (AAV) gene therapy is at 
 the forefront of modern medicine, offering the 
 potential to treat genetic diseases at their source. 
 This talk will guide attendees through the critical 
 early phases of AAV gene therapy development, 
 with a focus on what it takes to advance a candidate 
 therapy from the lab bench to a first-in-human 
 clinical trial. I will break down the science 
 behind AAV gene therapy, then move through the 
 investigational new drug (IND) submission process. 
 Drawing from seven years of experience at AskBio, 
 a pioneering gene therapy company that has grown 
 from a startup of 31 employees to a 1,000+ person 
 subsidiary of Bayer, I'll share firsthand insights 
 into the collaborative, cross-functional environment 
 of therapeutic development. Finally, the talk 
 will highlight career paths and academic foundations 
 that can lead to impactful roles in gene therapy 
 and biotechnology.\n\n

LOCATION:Warch Campus Center 204 - Cinema
END:VEVENT
END:VCALENDAR